BIOMAT Database Logo BIOMAT Database Logo

Effect of an aldose reductase inhibitor, SNK-860, on deficits in the electroretinogram of diabetic rats. 1995

N Hotta, and N Koh, and F Sakakibara, and J Nakamura, and Y Hamada, and K Naruse, and H Sasaki, and K Mizuno, and A Matsubara, and H Kakuta
Third Department of Internal Medicine, Nagoya University School of Medicine, Japan.

To determine the effect of an aldose reductase inhibitor, SNK-860, on the worsening of the electroretinogram (ERG) during a diabetic state, rats with streptozotocin-induced diabetes were administered SNK-860 (1 or 4 mg kg-1 orally) daily for 4 weeks. The effectiveness of SNK-860 in prolonging the peak latencies of oscillatory potentials in the b-wave of the electroretinogram of diabetic rats varied between these different waveform components (designated O1, O2 and O3). SNK-860 (4 mg kg-1 day-1) either completely or partially prevented the prolonged peak latencies at O1 and sigma(O1 + O2 + O3). The drug failed to shorten the latency of the O2 and O3 components, and produced only a modest reduction in retinal levels of sorbitol and fructose, with no increase in myo-inositol. There was a significant correlation between the state of the ERG (components O1 and sigma(O1 + O2 + O3)) and the retinal levels of sorbitol and fructose (P < 0.01), but not of myo-inositol. It is concluded that a better understanding of the mechanism by which SNK-860 acts may provide new insight into the pathogenesis of hyperglycaemic retinal dysfunction and help to establish effective therapy for diabetic retinopathy.

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D007294 Inositol An isomer of glucose that has traditionally been considered to be a B vitamin although it has an uncertain status as a vitamin and a deficiency syndrome has not been identified in man. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1379) Inositol phospholipids are important in signal transduction. Myoinositol,Chiro-Inositol,Mesoinositol,Chiro Inositol
D008297 Male Males
D012160 Retina The ten-layered nervous tissue membrane of the eye. It is continuous with the OPTIC NERVE and receives images of external objects and transmits visual impulses to the brain. Its outer surface is in contact with the CHOROID and the inner surface with the VITREOUS BODY. The outer-most layer is pigmented, whereas the inner nine layers are transparent. Ora Serrata
D003921 Diabetes Mellitus, Experimental Diabetes mellitus induced experimentally by administration of various diabetogenic agents or by PANCREATECTOMY. Alloxan Diabetes,Streptozocin Diabetes,Streptozotocin Diabetes,Experimental Diabetes Mellitus,Diabete, Streptozocin,Diabetes, Alloxan,Diabetes, Streptozocin,Diabetes, Streptozotocin,Streptozocin Diabete
D004596 Electroretinography Recording of electric potentials in the retina after stimulation by light. Electroretinographies
D000449 Aldehyde Reductase An enzyme that catalyzes reversibly the oxidation of an aldose to an alditol. It possesses broad specificity for many aldoses. EC 1.1.1.21. Aldose Reductase,Aldose Reductase Ia,Aldose Reductase Ib,Erythrose Reductase,Xylose Reductase,Reductase Ia, Aldose,Reductase Ib, Aldose,Reductase, Aldehyde,Reductase, Aldose,Reductase, Erythrose,Reductase, Xylose
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013012 Sorbitol A polyhydric alcohol with about half the sweetness of sucrose. Sorbitol occurs naturally and is also produced synthetically from glucose. It was formerly used as a diuretic and may still be used as a laxative and in irrigating solutions for some surgical procedures. It is also used in many manufacturing processes, as a pharmaceutical aid, and in several research applications. Glucitol,Medevac,Sorbilax,Yal,klysma Sorbit
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats

Related Publications

N Hotta, and N Koh, and F Sakakibara, and J Nakamura, and Y Hamada, and K Naruse, and H Sasaki, and K Mizuno, and A Matsubara, and H Kakuta
[Aldose reductase inhibitor SNK-860].
November 1997, Nihon rinsho. Japanese journal of clinical medicine,
N Hotta, and N Koh, and F Sakakibara, and J Nakamura, and Y Hamada, and K Naruse, and H Sasaki, and K Mizuno, and A Matsubara, and H Kakuta
Inhibitory effect of orally administered aldose reductase inhibitor SNK-860 on corneal polyol accumulation in galactose-fed rats.
September 1999, Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie,
N Hotta, and N Koh, and F Sakakibara, and J Nakamura, and Y Hamada, and K Naruse, and H Sasaki, and K Mizuno, and A Matsubara, and H Kakuta
Fidarestat (SNK-860), a potent aldose reductase inhibitor, normalizes the elevated sorbitol accumulation in erythrocytes of diabetic patients.
January 2002, Journal of diabetes and its complications,
N Hotta, and N Koh, and F Sakakibara, and J Nakamura, and Y Hamada, and K Naruse, and H Sasaki, and K Mizuno, and A Matsubara, and H Kakuta
Effects of an aldose reductase inhibitor, SNK-860, on the histopathological changes of retinal tissues in a streptozotocin-induced diabetic rat model.
October 1993, Acta medica Okayama,
N Hotta, and N Koh, and F Sakakibara, and J Nakamura, and Y Hamada, and K Naruse, and H Sasaki, and K Mizuno, and A Matsubara, and H Kakuta
The effect of an aldose reductase inhibitor (Epalrestat) on diabetic nephropathy in rats.
October 1994, Diabetes research and clinical practice,
N Hotta, and N Koh, and F Sakakibara, and J Nakamura, and Y Hamada, and K Naruse, and H Sasaki, and K Mizuno, and A Matsubara, and H Kakuta
Effects of glucose and SNK-860, an aldose reductase inhibitor, on the polyol pathway and chemiluminescence response of human neutrophils in vitro.
May 1995, Diabetic medicine : a journal of the British Diabetic Association,
N Hotta, and N Koh, and F Sakakibara, and J Nakamura, and Y Hamada, and K Naruse, and H Sasaki, and K Mizuno, and A Matsubara, and H Kakuta
Erythrocytic sorbitol contents in diabetic patients correlate with blood aldose reductase protein contents and plasma glucose levels, and are normalized by the potent aldose reductase inhibitor fidarestat (SNK-860).
January 2004, Journal of diabetes and its complications,
N Hotta, and N Koh, and F Sakakibara, and J Nakamura, and Y Hamada, and K Naruse, and H Sasaki, and K Mizuno, and A Matsubara, and H Kakuta
Effects of a Novel Aldose Reductase Inhibitor, Fidarestat (SNK-860), on Vibration Perception Threshold and Subjective Symptoms in Patients with Diabetic Polyneuropathy : An Open-Label Pilot Study.
January 2004, Clinical drug investigation,
N Hotta, and N Koh, and F Sakakibara, and J Nakamura, and Y Hamada, and K Naruse, and H Sasaki, and K Mizuno, and A Matsubara, and H Kakuta
Effects of an aldose reductase inhibitor on gastroenteropathy in streptozotocin-diabetic rats.
November 2003, Diabetes research and clinical practice,
N Hotta, and N Koh, and F Sakakibara, and J Nakamura, and Y Hamada, and K Naruse, and H Sasaki, and K Mizuno, and A Matsubara, and H Kakuta
Effect of an aldose reductase inhibitor on esophageal dysfunction in diabetic patients.
January 2005, Hepato-gastroenterology,
Copied contents to your clipboard!